pharmaceuticals
pharmaceuticals Articles
Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Spectrum Pharmaceuticals saw its shares make a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer study.
Published:
Last Updated:
Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.
Published:
Last Updated:
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.
Published:
Last Updated:
Conatus Pharmaceuticals shares took a big step back on Thursday after the firm announced that its midstage proof-of-concept clinical trial in liver transplant patients with fibrosis or cirrhosis...
Published:
Last Updated:
Rigel Pharmaceuticals saw its shares pull back early on Tuesday after the firm announced topline data from a midstage study.
Published:
Last Updated:
Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems to be the product of overall market sentiment as opposed to these...
Published:
Last Updated:
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
Published:
Last Updated:
Arrowhead Pharmaceuticals shares made a solid gain on Tuesday after the company gave an update on its midstage study of ARO-HBV in the treatment of patients with chronic hepatitis B virus infection.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
According to a recent analyst report by Janney, the National Institute of Health budget that was approved last Friday could be a big boost for some select biopharma stocks.
Published:
Last Updated:
AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory small cell lung cancer trial.
Published:
Last Updated:
Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.
Published:
AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer trial.
Published:
Last Updated: